ORIFARM NORWAY AS

Signals

1 flags

• ▼ Driftsunderskudd 2025 Siste driftsresultat er negativt (−1,2 mill kr).

ORIFARM NORWAY AS is registered as a limited company in Oslo, Oslo with organisation number 924595388. The business is classified under wholesale of pharmaceutical and medical goods (NACE 46.460). The company was incorporated in 2020. Registered share capital is NOK 30,000, divided into 300 shares. The company's stated purpose is: “Industri, handel og annen virksomhet som angår disse formål.”.

Former names: HERKULES INVEST 319 AS, DALMORE INVEST AS

Key figures · 2025

Operating profit

NOK −1.2m

▲ +100 %

Equity

NOK 18.2m

▼ −100 %

Est. value

NOK 70.4m

Financial health · 2025

Liquidity

5.11

Very good

Current assets ÷ current liabilities

Profitability

0.0%

Not satisfactory

Return on total assets

Solidity

11.0%

Satisfactory

Equity as a share of total capital

Who owns ORIFARM NORWAY AS?

ORIFARM GROUP AS Private shareholder

100.0%

ORIFARM NORWAY AS

· NOK −1.2m profit

ORIFARM NORWAY AS has 1 registered shareholder:

• ORIFARM GROUP AS 100.0%

All shareholders and roles →

Frequently asked questions about ORIFARM NORWAY AS

Who owns ORIFARM NORWAY AS?

ORIFARM GROUP AS is the largest registered owner, with 100.0%.

Who is the general manager of ORIFARM NORWAY AS?

Sverre Haugen is registered as general manager of ORIFARM NORWAY AS.

Where is ORIFARM NORWAY AS based?

ORIFARM NORWAY AS has its business address in Oslo.

Property

Business address Sandakerveien 138, 0484 Oslo

Cadastral unit 301-77/344/0/0

96 companies are registered at this address.

The address this company is registered at, from the company register and matched against the cadastre. It does not say who owns the property — a company may be a tenant, and the address is often its accountant's. Source: Brønnøysundregistrene and © Kartverket.

Source: Biztrac.no · Data from the Brønnøysund Register Centre and the Norwegian Tax Administration · Last updated 02.09.2026.